Table 1 Sample characteristics (independent variables): Baseline
Variables | TOTAL (n = 44) | Men (n = 32) | Women (n = 12) | P |
|---|---|---|---|---|
Socio-demographic variables | ||||
- Age (years) | 49.2 (11.9) | 50.7 (10.1) | 45 (15.5) | 0.897 |
- Legal representative | ||||
• No | 36 (81.8%) | 28 (63.8%) | 8 (18.2%) | 0.185 |
• Yes | 8 (18.2%) | 4 (9.1%) | 4 (9.1%) | |
- Household composition | ||||
• Individual | 12 (27.3%) | 10 (22.8%) | 2 (4.5%) | 0.285 |
• Horizontal | 3 (6.8%) | 1 (2.3%) | 2 (4.5%) | |
• Complete | 3 (6.8%) | 3 (6.8%) | 0 (0%) | |
• Own family home | 7 (15.9%) | 4 (9.1%) | 3 (6.8%) | |
• Other: Supervised flat | 19 (43.2%) | 14 (31.8%) | 5 (11.4%) | |
- Economic level | ||||
• High | 6 (13.6%) | 5 (11.4%) | 1 (2.3%) | 0.754 |
• Medium | 26 (59.1%) | 19 (43.2%) | 7 (15.9%) | |
• Low | 12 (27.3%) | 8 (18.2%) | 4 (9.1%) | |
- Level of education | ||||
• Uneducated | 4 (9.1%) | 3 (6.8%) | 1 (2.3%) | 0.009 |
• Primary | 19 (43.2%) | 9 (20.5%) | 10 (22.7%) | |
• Secondary | 17 (38.6%) | 16 (36.4%) | 1 (2.3%) | |
• University | 4 (9.1%) | 4 (9.1%) | 0 (0%) | |
- Area of residence | ||||
• Urban | 38 (86.4%) | 29 (65.9%) | 9 (20.5%) | 0.321 |
• Rural | 6 (13.6%) | 3 (6.8%) | 3 (6.8%) | |
Clinical Variables | ||||
-Psychiatric diagnosis | ||||
• Schizophrenia | 37 (84.1%) | 26 (59.1%) | 11 (25%) | 0.608 |
• Schizoaffective Disorder | 5 (11.4%) | 4 (9.1%) | 1 (2.3%) | |
• Delusional Disorder | 2 (4.5%) | 2 (4.5%) | 0 (0%) | |
- Duration of illness (years) | 21.6 (12.4) | 22.4 (11) | 16.6 (15.9) | 0.715 |
- Age at first hospitalisation (years) | 31.4 (11) | 30.7 (10.8) | 33.2 (11.5) | 0.572 |
- Consumption of toxics | ||||
• No | 15 (34.1%) | 9 (20.5%) | 6 (13.6%) | 0.284 |
• Yes | 29 (65.9%) | 23 (52.3%) | 6 (13.6%) | |
- Type of toxics | ||||
• Alcohol | 6 (13.6%) | 5 (11.3%) | 1 (2.3%) | 1.00 |
• Tobacco | 29 (65.9%) | 23 (52.3%) | 6 (13.6%) | |
• Cocaine | 3 (6.8%) | 2 (4.5%) | 1 (2.3%) | |
• Opioids | 2 (4.5%) | 1 (2.3%) | 1 (2.3%) | |
• Amphetamines | 3 (6.8%) | 2 (4.5%) | 1 (2.3%) | |
• Cannabis | 10 (22.7%) | 7 (15.9%) | 3 (6.8%) | |
- Cardio-metabolic diagnosis | ||||
• No | 24 (54.5%) | 15 (34.1%) | 9 (20.5%) | 0.095 |
• Yes | 20 (45.5%) | 17 (38.6%) | 3 (6.8%) | |
- Type Cardio-metabolic diagnosis | ||||
• AHT | 10 (22.7%) | 8 (18.2%) | 2 (4.5%) | 0.059 |
• DM | 7 (15.9%) | 5 (11.4%) | 2 (4.5%) | |
• Hyperlipemia | 14 (31.8%) | 13 (29.6%) | 1 (2.2%) | |
Therapeutic Variables | ||||
- Reason for Change: Antipsychotic Treatment | ||||
• Unchanged | 31 (70.5%) | 20 (45.5%) | 11 (25%) | 0.302 |
• Lack of efficiency | 5 (11.4%) | 5 (11.4%) | 0 (9.1%) | |
• Tolerability/safety issues | 2 (4.5%) | 1 (2.3%) | 1 (2.3%) | |
• Patient's own choice | 3 (6.8%) | 1 (2.3%) | 2 (4.5%) | |
• Other: Clinical improvement | 3 (6.8%) | 2 (4.5%) | 1 (2.3%) | |